Showing results (11-20 of 41) with videos related to
Sort By:
Pageof 5
HIV Medicine|February 9, 2008
European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adultsJ K Rockstroh, S Bhagani, Y Benhamou, et al.Journal of Viral Hepatitis|February 10, 2009
Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infectionA Sanvisens, I Serra, C Tural, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|April 29, 2006
Hepatotoxicity of antiretroviral drugs in HIV HCV patients with congenital coagulopathies followed at an Haemophilia Unit during a decadeS Sauleda, M Martorell, J I Esteban, et al.Journal of Viral Hepatitis|September 19, 2007
Safety and efficacy of an induction dose of pegylated interferon alpha-2a on early hepatitis C virus kinetics in HIV/HCV co-infected patients: the CORAL-1 multicentre pilot studyC Tural, R Solà, R Rubio, et al.Medicina Clinica|July 17, 1998
[Value of HIV-1 viral load and CD4 lymphocyte count as determinants of progression to AIDS and survival]J Romeu, M Balagué, L Ruiz, et al.Scandinavian Journal of Infectious Diseases|June 25, 1999
Short-term risk for AIDS-indicator diseases predicted by plasma HIV-1 RNA and CD4+ lymphocytesJ Romeu, M Balagué, L Ruiz, et al.The Journal of Infectious Diseases|April 16, 1998
Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patientsC Tural, J Romeu, G Sirera, et al.AIDS (London, England)|August 28, 1999
Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy. Spanish CMV-AIDS Study GroupJ L Casado, J Arrizabalaga, M Montes, et al.AIDS (London, England)|April 19, 2000
Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppressionL Ruiz, J Martinez-Picado, J Romeu, et al.Journal of Viral Hepatitis|September 15, 2011
Natural prevalence of HCV minority variants that are highly resistant to NS3/4A protease inhibitorsS Franco, R Bellido, E Aparicio, et al.Pageof 5